• OPEN AN ACCOUNT
Indian Indices
Nifty
24,346.70 12.50
(0.05%)
Sensex
80,501.99 259.75
( 0.32%)
Bank Nifty
55,115.35 28.20
( 0.05%)
Nifty IT
35,891.85 96.90
( 0.27%)
Global Indices
Nasdaq
41,337.14 563.18
(1.38%)
Dow Jones
5,708.24 83.10
(1.48%)
Hang Seng
36,831.70 379.40
(1.04%)
Nikkei 225
8,596.35 99.55
(1.17%)
Forex
USD-INR
84.62 -0.14
(-0.16%)
EUR-INR
95.64 -0.64
(-0.67%)
GBP-INR
112.53 -0.71
(-0.62%)
JPY-INR
0.59 -0.01
(-1.42%)

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524804
INE406A01037
335.4746309
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AUROPHARMA
37.04
71021.62
EPS(TTM)
Face Value()
Div & Yield %
32.72
1
0.37
 

Jindal Leasefin Ltd - Board Meeting Intimation for Consideration And Approval Of Standalone Un-Audited Financial Results Of The Company For The Quarter Ended On 31St December 2024.
Feb 07,2025
Jindal Leasefin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the Standalone Un-Audited Financial Results of the Company for the quarter ended on 31st December 2024.